These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15977694)

  • 1. Anthrax vaccines.
    Splino M; Patocka J; Prymula R; Chlibek R
    Ann Saudi Med; 2005; 25(2):143-9. PubMed ID: 15977694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging non-human primate correlates of protection to reassess the Anthrax Vaccine Adsorbed booster schedule in humans.
    Schiffer JM; Chen L; Dalton S; Niemuth NA; Sabourin CL; Quinn CP
    Vaccine; 2015 Jul; 33(31):3709-16. PubMed ID: 26072016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis against anthrax.
    Splino M; Patocka J
    Acta Medica (Hradec Kralove); 2002; 45(3):85-8. PubMed ID: 12515043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.
    Wright JG; Plikaytis BD; Rose CE; Parker SD; Babcock J; Keitel W; El Sahly H; Poland GA; Jacobson RM; Keyserling HL; Semenova VA; Li H; Schiffer J; Dababneh H; Martin SK; Martin SW; Marano N; Messonnier NE; Quinn CP
    Vaccine; 2014 Feb; 32(8):1019-28. PubMed ID: 24373307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
    Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
    Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selected research problems of anthrax vaccine development].
    Zakowska D; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):505-12. PubMed ID: 20120948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.
    Wright JG; Quinn CP; Shadomy S; Messonnier N;
    MMWR Recomm Rep; 2010 Jul; 59(RR-6):1-30. PubMed ID: 20651644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.
    Sivko GS; Stark GV; Tordoff KP; Taylor KL; Glaze E; VanRaden M; Schiffer JM; Hewitt JA; Quinn CP; Nuzum EO
    Vaccine; 2016 Dec; 34(51):6518-6528. PubMed ID: 27155494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is new always better than old?: The development of human vaccines for anthrax.
    Baillie LW
    Hum Vaccin; 2009 Dec; 5(12):806-16. PubMed ID: 19786839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.
    Campbell JD; Clement KH; Wasserman SS; Donegan S; Chrisley L; Kotloff KL
    Hum Vaccin; 2007; 3(5):205-11. PubMed ID: 17881903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with a Recombinant, Pseudomonas fluorescens-Expressed, Mutant Form of Bacillus anthracis-Derived Protective Antigen Protects Rabbits from Anthrax Infection.
    Reed MD; Wilder JA; Mega WM; Hutt JA; Kuehl PJ; Valderas MW; Chew LL; Liang BC; Squires CH
    PLoS One; 2015; 10(7):e0130952. PubMed ID: 26207820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.
    Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM;
    Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990-2007.
    Niu MT; Ball R; Woo EJ; Burwen DR; Knippen M; Braun MM;
    Vaccine; 2009 Jan; 27(2):290-7. PubMed ID: 18992783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of the humoral and cellular immunity induced by live A16R attenuated spore and AVA-like anthrax vaccine in mice.
    Lv J; Zhang YY; Lu X; Zhang H; Wei L; Gao J; Hu B; Hu WW; Hu DZ; Jia N; Feng X
    Biologicals; 2017 Mar; 46():130-138. PubMed ID: 28215694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.
    Martin SW; Tierney BC; Aranas A; Rosenstein NE; Franzke LH; Apicella L; Marano N; McNeil MM
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):393-401. PubMed ID: 15717323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.
    Longstreth J; Skiadopoulos MH; Hopkins RJ
    Expert Rev Vaccines; 2016 Dec; 15(12):1467-1479. PubMed ID: 27792416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity.
    Pittman PR; Fisher D; Quinn X; Schmader T; Barrera-Oro JG
    Vaccine; 2013 Oct; 31(44):5009-14. PubMed ID: 24026013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine.
    Marcus H; Danieli R; Epstein E; Velan B; Shafferman A; Reuveny S
    Infect Immun; 2004 Jun; 72(6):3471-7. PubMed ID: 15155654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.
    Schiffer JM; McNeil MM; Quinn CP
    Expert Rev Vaccines; 2016 Sep; 15(9):1151-62. PubMed ID: 26942655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.